These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 26144699)
1. (131)I treatment in Differentiated Thyroid Cancer and End-Stage Renal Disease. Ortega AJ; Vázquez RG; Cuenca JI; Brocca MA; Castilla J; Martínez JM; González EN Rev Esp Med Nucl Imagen Mol; 2016; 35(1):29-33. PubMed ID: 26144699 [TBL] [Abstract][Full Text] [Related]
2. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947 [TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy for papillary and follicular thyroid carcinoma. Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549 [TBL] [Abstract][Full Text] [Related]
4. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
5. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer. Sacks W; Wong RM; Bresee C; Braunstein GD Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116 [TBL] [Abstract][Full Text] [Related]
6. A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer. Ben Ghachem T; Yeddes I; Meddeb I; Bahloul A; Mhiri A; Slim I; Ben Slimene MF Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):655-660. PubMed ID: 27225282 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature. Zhang X; Liu DS; Luan ZS; Zhang F; Liu XH; Zhou W; Zhong SF; Lai H Clin Transl Oncol; 2018 Jul; 20(7):928-935. PubMed ID: 29119458 [TBL] [Abstract][Full Text] [Related]
8. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer]. Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452 [TBL] [Abstract][Full Text] [Related]
9. Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis. Mello AM; Isaacs R; Petersen J; Kronenberger S; McDougall IR Clin Nucl Med; 1994 Sep; 19(9):776-81. PubMed ID: 7982310 [TBL] [Abstract][Full Text] [Related]
10. Iodine 131 treatment for differentiated thyroid carcinoma in patients with end stage renal failure: dosimetric, radiation safety, and practical considerations. Alevizaki C; Molfetas M; Samartzis A; Vlassopoulou B; Vassilopoulos C; Rondogianni P; Kottou S; Hadjiconstantinou V; Alevizaki M Hormones (Athens); 2006; 5(4):276-87. PubMed ID: 17178703 [TBL] [Abstract][Full Text] [Related]
11. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I. Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552 [TBL] [Abstract][Full Text] [Related]
12. Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing dialysis for chronic renal failure: a dosimetric method. Jiménez RG; Moreno AS; Gonzalez EN; Simón FJL ; Rodriguez JR; Jimenez JC; Córdoba MH; Albertino RV; Jimenez RA Thyroid; 2001 Nov; 11(11):1031-4. PubMed ID: 11762712 [TBL] [Abstract][Full Text] [Related]
13. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration. Patel SS; Goldfarb M J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma. Yang Z; Flores J; Katz S; Nathan CA; Mehta V Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057 [TBL] [Abstract][Full Text] [Related]
15. Iodine 131 ablation therapy for a patient on maintenance haemodialysis. Howard N; Glasser M Br J Radiol; 1981 Mar; 54(639):259. PubMed ID: 7470791 [No Abstract] [Full Text] [Related]
16. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma. Salvatori M; Luster M Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):821-8. PubMed ID: 20186542 [No Abstract] [Full Text] [Related]
17. [Treatment with (131)I of thyroid remnants in a patient with papillary thyroid carcinoma and end-stage chronic renal failure]. Andres A; Tardín L; Santapau A; Razola P; Prats E; Parra A; Rivas MA; Ruiz P; Alvarez R; Camara A; Banzo J Rev Esp Med Nucl; 2010; 29(1):32-5. PubMed ID: 20018412 [TBL] [Abstract][Full Text] [Related]
18. Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients. Castagna MG; Cevenini G; Theodoropoulou A; Maino F; Memmo S; Claudia C; Belardini V; Brianzoni E; Pacini F Eur J Endocrinol; 2013 Jul; 169(1):23-9. PubMed ID: 23594687 [TBL] [Abstract][Full Text] [Related]
19. The biodistribution of radioiodine on posttherapy iodine-131 scans in thyroid cancer patients with chronic renal failure. Aktaş A; Kavak K; Kocabaş B; Aras M; Tütüncü NB; Gençoğlu A Nucl Med Commun; 2008 Nov; 29(11):943-8. PubMed ID: 18836371 [TBL] [Abstract][Full Text] [Related]
20. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis. Daumerie C; Vynckier S; Caussin J; Jadoul M; Squifflet JP; de Patoul N; Wambersie A Thyroid; 1996 Aug; 6(4):301-4. PubMed ID: 8875750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]